etavopivat
·Code: FT-4202
etavopivat: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Forma Therapeutics Holdings, Inc. (FMTX) | Phase 2 |
Clinical Trials (1)
A Phase 2 Open-Label Study to Evaluate Safety and Clinical Activity of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
Frequently asked questions
Who is developing etavopivat?
etavopivat is being developed by Forma Therapeutics Holdings, Inc..
How many clinical trials involve etavopivat?
BioSniper tracks 1 clinical trial involving etavopivat.
Get deeper analysis on etavopivat
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis